{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03273",
    "Peptide Name": "BING (Ile-rich; natural AMPs; fish, animals; UCLL1)",
    "Source": "plasma, medaka,Oryzias latipes",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "IRIILRAQGALKI",
    "Sequence Length": 13,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Anti-MRSA"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Beta",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 3,
    "Boman Index": 0.52,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "62%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Activity: Active against both Gram+ and Gram- bacteria. Active against Gram+ S. Faecalis (MIC 50 ug/ml), S. pyogenes ATCC 14289 (MIC 50 ug/ml),  S. aureus ATCC 6538 or ATCC 29213 or MRSA ATCC BAA-41 or 44 (MIC 20-64 ug/ml), S. epidermidis ATCC 12228 (MIC 4 ug/ml), B. subtilis 168 (MIC 16 ug/ml),  Gram- bacteria A. hydrophila ATCC 49140 (MIC 20 ug/ml), V. alginolyticus ATCC 33840 (MIC 50 ug/ml), E. tarda PE210 (MIC 10 ug/ml), E. cloacae BAA-1143 (MIC 32 ug/ml), A. baumannii ATCC 19606 (MIC 10 ug/ml),  E. coli ATCC 10536  or pathogenic E. coli (MIC 5 ug/ml),  E. coli BL21 (DE3) (MIC 8 ug/ml),  K. pneumoniae (NDM-1) ATCC BAA-2470 (MIC 32 ug/ml), E. coli (NDM-1) ATCC BAA-2469 (MIC 16 ug/ml),  NDM-1/BL21 (DE3), SHV-1/BL21 (DE3) (MIC 4 ug/ml), TEM-1/BL21 (DE3) (MIC 8 ug/ml), MCR-1/BL21 (DE3) (MIC 16 ug/ml),  P. aeruginosa A (MIC 50 ug/ml).  Reg. 7/2021",
    "Author": "Dong M, Kwok SH, Humble JL, Liang Y, Tang SW, Tang KH, Tse MK, Lei JH, Ramalingam R, Koohi-Moghadam M, Au DWT, Sun H, Lam YW.2021",
    "Reference": "Sci Rep. 2021 Jun 9;11(1):12219. doi: 10.1038/s41598-021-91765-4.PubMed",
    "Title": "BING, a novel antimicrobial peptide isolated from Japanese medaka plasma, targets bacterial envelope stress response by suppressing cpxR expression"
  },
  "3D Structure": []
}